Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Spring;2(1):30-41.

Clinical utility of indigenously formulated single-vial lyophilized HYNIC-TOC kit in evaluating Gastro-entero Pancreatic neuro endocrine tumours

Ajit S Shinto  1 , K Kamaleshwaran  1 , K Vyshak  1 , Natarajan Sudhakar  1 , Sharmila Banerjee  2 , Aruna Korde  2 , Grace Samuel  2 , Madhav Mallia  2
Affiliations

Clinical utility of indigenously formulated single-vial lyophilized HYNIC-TOC kit in evaluating Gastro-entero Pancreatic neuro endocrine tumours

Ajit S Shinto et al. Asia Ocean J Nucl Med Biol. 2014 Spring.

Abstract

Objectives: The objective of this study was to evaluate the performance and utility of (99m)Tc HYNIC-TOC planar scintigraphy and SPECT/CT in the diagnosis, staging and management of gastroenteropancreatic neuroendocrine tumors (GPNETs).

Methods: 22 patients (median age, 46 years) with histologically proven gastro- entero- pancreatic NETs underwent (99m)Tc HYNIC-TOC whole body scintigraphy and regional SPECT/CT as indicated. Scanning was performed after injection of 370-550 MBq (10-15 mCi) of (99m)Tc HYNIC-TOC intravenously. Images were evaluated by two experienced nuclear medicine physicians both qualitatively as well as semi quantitatively (tumor to background and tumor to normal liver ratios on SPECT -CT images). Results of SPECT/CT were compared with the results of conventional imaging. Histopathology results and follow-up somatostatin receptor scintigraphy with (99m)Tc HYNIC TOC or conventional imaging with biochemical markers were considered to be the reference standards.

Results: (99m)Tc HYNIC TOC showed sensitivity and specificity of 87.5% and 85.7%, respectively, for primary tumor and 100% and 86% for metastases. It was better than conventional imaging modalities for the detection of both primary tumor (P<0.001) and metastases (P<0.0001). It changed the management strategy in 6 patients (31.8%) and supported management decisions in 8 patients (36.3%).

Conclusion: (99m)Tc HYNIC TOC SPECT/CT appears to be a highly sensitive and specific modality for the detection and staging of GPNETs. It is better than conventional imaging for the evaluation of GPNETs and can have a significant impact on patient management and planning further therapeutic options.

Keywords: HYNIC TOC; Neuroendocrine tumor; SPECT CT.

PubMed Disclaimer

Figures

Figure 1
Figure 1
a) Whole body anterior and posterior Tc-99m-HYNIC-TOC images showing primary pancreatic neuroendocrine tumour. b) SPECT, CT and fused SPECT/CT slices localized uptake to the pancreatic tumour
Figure 2
Figure 2
Transaxial SPECT, CT and fused SPECT/CT as well as coronal image shows uptake in the duodenum and liver lesions.
Figure 3
Figure 3
(a) Whole body anterior and posterior Tc-99m-HYNIC-TOC images showing multiple liver metastasis. (b) SPECT, CT and SPECT/CT localized uptake to the liver lesions.
Figure 4
Figure 4
(a)Whole body Tc-99m-HYNIC-TOC images showing two focal uptake, one in the right thigh and other just below bladder. Also photopenic area noted in the liver lesion suggestive of necrosis.(b) Transaxial SPECT, CT and SPECT/CT showing uptake in the neck of right femur and left pubis.
See this image and copyright information in PMC

References

    1. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97:934–59. - PubMed
    1. Sutliff VE, Doppman JL, Gibril F, Venzon D J, Yu F, Serrano J, et al. Growth of newly diagnosed, untreated metastatic gastrinomas and predictors of growth patterns. J Clin Oncol. 1997;15:2420–31. - PubMed
    1. Fraker DL, Jensen RT. Pancreatic endocrine tumors. In: DeVita VT, Hellman S, Rosemberg SA, editors. Cancer: principles and practice of oncology. 5th ed. Philadelphia: PA: Lippincott-Raven; 1997. pp. 1678–1704.
    1. Eriksson B, Oberg K, Skogseid B. Neuroendocrine pancreatic endocrine tumors: clinical findings in a prospective study of 84 patients. Acta Oncol. 1989;28:373–7. - PubMed
    1. Schillaci O, Spanu A, Scopinaro F, Falchi A, Danieli R, Marongiu P, et al. Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors. J Nucl Med. 2003;44:359–68. - PubMed

LinkOut - more resources